Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.

Published

Journal Article

Duchenne and Becker muscular dystrophy are caused by defects in the dystrophin gene, and are candidates for treatment by gene therapy. We have shown previously that overexpression of a full-length dystrophin cDNA prevents the development of dystrophic symptoms in mdx mice. We show here that this functional correction can be achieved by expressing the full-length muscle isoform at a lower level than is present in control animals. Gene therapy for DMD may necessitate the use of truncated dystrophin mini-genes to accommodate the limited cloning capacity of current-generation viral delivery vectors. We have constructed both murine and human mini-genes deleted for exons 17-48, and have demonstrated that expression of either mini-gene can almost completely prevent the development of dystrophic symptoms in transgenic mdx mice. These results suggest that viral-mediated expression of moderate levels of a truncated dystrophin could be an effective treatment for DMD.

Full Text

Duke Authors

Cited Authors

  • Phelps, SF; Hauser, MA; Cole, NM; Rafael, JA; Hinkle, RT; Faulkner, JA; Chamberlain, JS

Published Date

  • August 1995

Published In

Volume / Issue

  • 4 / 8

Start / End Page

  • 1251 - 1258

PubMed ID

  • 7581361

Pubmed Central ID

  • 7581361

International Standard Serial Number (ISSN)

  • 0964-6906

Digital Object Identifier (DOI)

  • 10.1093/hmg/4.8.1251

Language

  • eng

Conference Location

  • England